Human African trypanosomiasis

被引:4
|
作者
Buscher, Philippe [1 ]
Cecchi, Giuliano [2 ]
Jamonneau, Vincent [3 ]
Priotto, Gerardo [4 ]
机构
[1] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium
[2] Food & Agr Org United Nat, Sub Reg Off Eastern Afr, Addis Ababa, Ethiopia
[3] Inst Rech Dev, UMR INTERTRYP, Montpellier, France
[4] WHO, Control Neglected Trop Dis Innovat & Intensified, Geneva, Switzerland
关键词
EFLORNITHINE COMBINATION THERAPY; RAPID DIAGNOSTIC-TEST; SLEEPING-SICKNESS; BRUCEI-GAMBIENSE; CEREBROSPINAL-FLUID; PARASITIC INFECTIONS; ANIMAL RESERVOIRS; TSETSE-FLIES; RISK-FACTORS; SERODIAGNOSIS;
D O I
10.1016/S0140-6736(17)31510-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost invariably progresses to death unless treated. Human African trypanosomiasis caused devastating epidemics during the 20th century. Thanks to sustained and coordinated efforts over the past 15 years, the number of reported cases has fallen to an historically low level. Fewer than 3000 cases were reported in 2015, and the disease is targeted for elimination by WHO. Despite these recent successes, the disease is still endemic in parts of sub-Saharan Africa, where it is a considerable burden on rural communities, most notably in central Africa. Since patients are also reported from non-endemic countries, human African trypanosomiasis should be considered in differential diagnosis for travellers, tourists, migrants, and expatriates who have visited or lived in endemic areas. In the absence of a vaccine, disease control relies on case detection and treatment, and vector control. Available drugs are suboptimal, but ongoing clinical trials provide hope for safer and simpler treatments.
引用
收藏
页码:2397 / 2409
页数:13
相关论文
共 50 条
  • [1] Human African trypanosomiasis
    Lejon, Veerle
    Lindner, Andreas K.
    Franco, Jose R.
    LANCET, 2025, 405 (10482) : 937 - 950
  • [2] Human African trypanosomiasis in endemic populations and travellers
    Blum, J. A.
    Neumayr, A. L.
    Hatz, C. F.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (06) : 905 - 913
  • [3] Treatment options for second-stage gambiense human African trypanosomiasis
    Eperon, Gilles
    Balasegaram, Manica
    Potet, Julien
    Mowbray, Charles
    Valverde, Olaf
    Chappuis, Francois
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (11) : 1407 - 1417
  • [4] Chemotherapy against human African trypanosomiasis: Is there a road to success?
    Burri, Christian
    PARASITOLOGY, 2010, 137 (14) : 1987 - 1994
  • [5] Human African Trypanosomiasis Progress and Stagnation
    Bottieau, Emmanuel
    Clerinx, Jan
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (01) : 61 - +
  • [6] Epidemiology of human African trypanosomiasis
    CONTROL AND SURVEILLANCE OF HUMAN AFRICAN TRYPANOSOMIASIS, 2013, 984 : 3 - 41
  • [7] Human African trypanosomiasis, chemotherapy and CNS disease
    Rodgers, Jean
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 211 (1-2) : 16 - 22
  • [8] Future treatment options for human African trypanosomiasis
    Jones, Amy J.
    Avery, Vicky M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (12) : 1429 - 1432
  • [9] Gambiense human African trypanosomiasis: the bumpy road to elimination
    Hasker, Epco
    Hope, Andrew
    Bottieau, Emmanuel
    CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (05) : 384 - 389
  • [10] Human African trypanosomiasis
    Brun, Reto
    Blum, Johannes
    Chappuis, Francois
    Burri, Christian
    LANCET, 2010, 375 (9709) : 148 - 159